Navigation Links
Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment

The survival rate of patients with testicular cancer has increased significantly over the past several years. What more, new research has now shown that fatherhood is a reachable possibility for many men who survive the disease.//

Testicular cancer is the most common form of cancer among men ages 20 to 40 and is slightly more common on the right side than on the left. The cause for the cancer is not known exactly. However, a combination of congenital (present right form birth) and acquired factors is believed to play a significant role.

The most common symptom associated with testicular cancer is painless enlargement of the testis accompanied by a sensation of heaviness. Self-examination plays a very important role in the early detection and treatment of testicular cancer. Surgery, radiotherapy and chemotherapy are the treatment options available.

A ray of hope left for the patients affected with testicular cancer is that it has a high cure rate, if detected early. However, the treatment has been known to affect the fertility potential of the patient. A follow up study combined with research purpose, conducted on a group of testicular cancer patients revealed that about one-third of the follow up patients attempted to father a child after treatment. Seventy-one percent of the men were successful within 15 years of treatment and 76 percent had the same success within 20 years.

Furthermore, the chance of successful conception was found to be dependent on the type of treatment as anticipated. Men treatment with high doses of chemotherapy had a 48 % success while the success rate for those followed by surveillance alone after the cancerous testicle was removed was much higher (92 %). Assisted reproductive techniques have helped these patients to a larger extent (22 %). The study results highlight the finding that the ability to conceive has increased over the years. It would be important however to preserve the sperm sample by c ryopreservation prior to chemotherapy as it is impossible to predict the fertility outcome on an individual basis.
'"/>




Related medicine news :

1. Fertility After Testicular Cancer Questioned
2. Life After Testicular Cancer
3. New Screening Method Found To Detect Testicular Cancer In Its Initial Stages
4. Testicular cancer linked to high cholesterol
5. Carboplatin Drug Is More Effective Than Radiation Therapy For Testicular Cancer
6. Treating Testicular Cancer With A Single Dose Of Chemotherapy
7. Testicular cancer identified
8. New Treatment Option For Testicular Cancer
9. Decline in Paternity Rates Following Treatment for Testicular Cancer
10. Human Testicular Cells Would Help In Stem Cell Research
11. An Eye on Increase in Testicular Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: